[HTML][HTML] Inter-society consensus document on treatment and prevention of bronchiolitis in newborns and infants

E Baraldi, M Lanari, P Manzoni, GA Rossi… - Italian journal of …, 2014 - Springer
Acute bronchiolitis is the leading cause of lower respiratory tract infection and hospitalization
in children less than 1 year of age worldwide. It is usually a mild disease, but some children …

Leukotriene inhibitors for bronchiolitis in infants and young children

F Liu, J Ouyang, AN Sharma, S Liu… - Cochrane Database …, 2015 - cochranelibrary.com
Background Bronchiolitis is an acute inflammatory illness of the bronchioles common among
infants and young children. It is often caused by the respiratory syncytial virus (RSV) …

Bronchiolitis therapies and misadventures

RSN Linssen, MS Schechter, BK Rubin - Paediatric Respiratory Reviews, 2023 - Elsevier
Viral bronchiolitis, which is most commonly caused by an infection with the respiratory
syncytial virus (RSV), can lead to respiratory difficulties in young children which may require …

Treatment of bronchiolitis: state of the art

L Da Dalt, S Bressan, F Martinolli, G Perilongo… - Early Human …, 2013 - Elsevier
Bronchiolitis is a leading cause of acute illness and hospitalization for infants and young
children worldwide. It is usually a mild disease, but the few children developing severe …

Recent advances in management of bronchiolitis

N Verma, R Lodha, SK Kabra - Indian pediatrics, 2013 - Springer
Background Bronchiolitis is one of the major causes for hospital admissions in infants.
Managing bronchiolitis, both in the outpatient and inpatient setting remains a challenge to …

[HTML][HTML] Utility of the Global Respiratory Severity Score for predicting the need for respiratory support in infants with respiratory syncytial virus infection

J Kubota, D Hirano, S Okabe, K Yamauchi, R Kimura… - Plos one, 2021 - journals.plos.org
Background Respiratory syncytial virus (RSV) is a common cause of acute respiratory
infection in children. One of the most important strategies for treatment of an RSV infection is …

Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection

RA Loaiza, MA Farías, CA Andrade… - Expert Review of Anti …, 2024 - Taylor & Francis
Introduction The human respiratory syncytial virus (hRSV) is one of childhood diseases'
most common respiratory pathogens and is highly associated with lower respiratory tract …

Montelukast, current indications and prospective future applications

N Kittana, S Hattab, A Ziyadeh-Isleem… - Expert review of …, 2016 - Taylor & Francis
Introduction: Montelukast is recommended for the treatment of asthma, exercise-induced
bronchospasm and allergic rhinitis. Several trials demonstrated potential therapeutic effects …

Évaluation de l'effet de la kinésithérapie respiratoire avec augmentation du flux expiratoire dans la prise en charge de la première bronchiolite du nourrisson en ville

D Evenou, S Sebban, C Fausser, D Girard - Kinésithérapie, la revue, 2017 - Elsevier
Résumé Le protocole de recherche BRONKILIB est une étude ambulatoire, non
interventionnelle, prospective, multicentrique dont l'objectif principal a été d'évaluer l'effet de …

Characteristics of respiratory syncytial virus-induced bronchiolitis co-infection with Mycoplasma pneumoniae and add-on therapy with montelukast

SH Wu, XQ Chen, X Kong, PL Yin, L Dong… - World Journal of …, 2016 - Springer
Abstract Background The influence of Mycoplasma pneumoniae (MP) infection on
bronchiolitis remains unclear. Additionally, reports on the efficacies of leukotriene receptor …